Evidence map›Paper›PMID 42675628›Full record

ArticleJournal of cellular and molecular medicine2026

Single-Cell Immune Profiling Suggests Non-Classical Monocyte Is Associated Immunodepression in Tuberculosis Treatment Non-Responders.

Yiqun Xiong, Yahong Qu, Ying Wang, Dongliang Zhang, Hao Shen, Weixin Wang, Junshun Gao, ZhenBo Wang, Zhihong Shen, Yang Che

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yiqun XiongDepartment of Infectious Diseases, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, Zhejiang, China.
Yahong QuDepartment of Infectious Diseases, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, Zhejiang, China.
Ying WangDepartment of Infectious Diseases, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, Zhejiang, China.
Dongliang ZhangInstitute of Tuberculosis Prevention and Control, Ningbo Municipal Center for Disease Control and Prevention, Ningbo, Zhejiang, China.
Hao ShenCosmos Wisdom Biotech Co. Ltd, Hangzhou, China.
Weixin WangCosmos Wisdom Biotech Co. Ltd, Hangzhou, China.ORCID 0000-0002-2765-2629
Junshun GaoCosmos Wisdom Biotech Co. Ltd, Hangzhou, China.ORCID 0009-0008-9974-9412
ZhenBo WangCosmos Wisdom Biotech Co. Ltd, Hangzhou, China.ORCID 0009-0000-8693-2527
Zhihong ShenDepartment of Infectious Diseases, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, Zhejiang, China.
Yang CheInstitute of Tuberculosis Prevention and Control, Ningbo Municipal Center for Disease Control and Prevention, Ningbo, Zhejiang, China.ORCID 0000-0003-3085-8123

Funding

Natural Science Foundation of Zhejiang Province LTGY23H190001Ningbo Public Welfare Science and Technology Program Projec 2024S040Ningbo Top Medical and Health Research Program 2023020713
6 · The paper itself

Abstract

Sputum culture conversion (SCC) at 2 months is an early indicator of tuberculosis (TB) treatment response, yet the associated immune alterations remain incompletely defined. We performed single-cell RNA sequencing on peripheral blood mononuclear cells from eight TB patients, stratified by 2-month SCC status. Non-responders showed a relative enrichment of non-classical monocytes and higher TB progression risk scores. CellChat analysis inferred altered IL16 and TRAIL communication involving these cells. CD4+ Tregs in non-responders showed higher LGALS9 expression and inferred GALECTIN signalling towards cytotoxic lymphocyte subsets; cell-level LGALS9 co-expression correlated with HAVCR2 and TIGIT in non-responders. Mature NK subclusters showed distinct enrichment profiles. These results describe an observational, transcriptomic and computationally inferred immune network associated with early treatment non-response. They generate candidate biomarkers and hypotheses for prospective protein-level and functional validation.

Indexed as

Immune ToleranceMonocytesSingle-Cell AnalysisTuberculosisBiomarkersFemaleGalectinsHepatitis A Virus Cellular Receptor 2HumansMaleMycobacterium tuberculosisSingle-Cell Gene Expression AnalysisSputumT-Lymphocytes, RegulatoryBiomarkersGalectinsHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2LGALS9 protein, humanGALECTINIL‐16immunosuppressionnon‐classical monocytessingle‐cell RNA sequencingsputum culture conversionTRAILtuberculosis

Identifiers

PMID42675628
PMCPMC13530280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.